ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Effectiveness of Mycobacterium tuberculosis recombinant proteins-coated gold nanoparticles in improving the interferon-gamma release assay test

Eficacia de las nanopartículas de oro recubiertas de proteínas recombinantes de Mycobacterium tuberculosis para mejorar la prueba de ensayo de liberación de interferón gamma

Najmeh Jomehpoura,b, Mojtaba Sankianc,d,

Corresponding author

sankianm@mums.ac.ir

Corresponding authors.

, Saman Soleimanpoura,b,e,

Corresponding author

soleimanpours@mums.ac.ir

Corresponding authors.

, Mohammad Derakhshanb, Kiarash Ghazvinib, Safora Pordelc, Malihe Moghadamd

a Antimicrobial Resistance Research Centre, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

b Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

c Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

d Immunobiochemistry Laboratory, Immunology Research Center, Bu-Ali Research Institute, Mashhad, Iran

e Reference Tuberculosis Laboratory, Mashhad University of Medical Sciences, Mashhad, Iran

Read

Not available

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2024.06.015

The statistics are updated each day

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Uncommon lip lesions in an HIV...

10.1016/j.eimc.2024.06.017

Tolerance of Atovacuona/proguanil in off-label...

10.1016/j.eimc.2024.06.012

Resumen ejecutivo de las Guías Española de...

Enferm Infecc Microbiol Clin. 2024;42:380-5

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter